Artubal, Alberto T.

HRN: 21-04-24  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2023
CEFTAZIDIME 1GM (VIAL)
08/19/2023
08/26/2023
IV
1g
Q8
Pneumonia
Checking Final Appropriateness 
08/30/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/30/2023
09/06/2023
IV
750mg
Q24
CAP-MR

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: